| scholarly article | Q13442814 |
| P2093 | author name string | Mario Marchi | |
| Paolo Cavazzani | |||
| Maurizio Raiteri | |||
| Concetta Viola | |||
| Francesca Risso | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1071-1078 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals | |
| P478 | volume | 80 |
| Q44919586 | A cholinergic synaptically triggered event participates in the generation of persistent activity necessary for eye fixation. |
| Q43232392 | A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study |
| Q37081416 | A psychobiological framework of the substrates that mediate nicotine use during adolescence |
| Q28265120 | ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders |
| Q90252559 | Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task |
| Q39399401 | Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease |
| Q38063303 | Allosteric modulators of α4β2 nicotinic acetylcholine receptors: a new direction for antidepressant drug discovery |
| Q92856555 | Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease Progression |
| Q36900018 | Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. |
| Q36673034 | Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development. |
| Q42445437 | Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons |
| Q44532497 | Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. |
| Q34121565 | Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? |
| Q92751428 | Bipolar Cell Type-Specific Expression and Conductance of Alpha-7 Nicotinic Acetylcholine Receptors in the Mouse Retina |
| Q30422037 | Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning |
| Q36042479 | Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions |
| Q42058396 | Chronic nicotine alters nicotinic receptor-induced presynaptic Ca2+ responses in isolated nerve terminals |
| Q42453415 | Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release |
| Q37454529 | Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. |
| Q64238005 | Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats |
| Q42554387 | Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry |
| Q35506425 | Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning |
| Q47112591 | Distinct cytokine patterns may regulate the severity of neonatal asphyxia-an observational study. |
| Q34654483 | Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity |
| Q46615897 | EFFECT of nicotine on hippocampal nicotinic acetylcholine alpha7 receptor and NMDA receptor subunits 2A and 2B expression in young and old rats |
| Q46490757 | Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats |
| Q38873131 | Effects of chronic inhalation of electronic cigarettes containing nicotine on glial glutamate transporters and α-7 nicotinic acetylcholine receptor in female CD-1 mice |
| Q46560369 | Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism |
| Q37580731 | Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines |
| Q37046788 | Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum. |
| Q82029286 | Functional neurochemistry of the basal ganglia |
| Q37282375 | Global actions of nicotine on the striatal microcircuit. |
| Q34997975 | Glutamate-dopamine crosstalk in the rat prefrontal cortex is modulated by Alpha7 nicotinic receptors and potentiated by PNU-120596. |
| Q34359105 | Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction |
| Q24648924 | Glutamatergic substrates of drug addiction and alcoholism |
| Q35147443 | Impairment of reward-related learning by cholinergic cell ablation in the striatum |
| Q48507588 | In vivo effects of the anatoxin-a on striatal dopamine release |
| Q48451558 | In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum |
| Q26781849 | Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease |
| Q38832886 | Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015). |
| Q42434820 | Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo |
| Q42790340 | Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives |
| Q48041301 | Kynurenine pathway and white matter microstructure in bipolar disorder |
| Q26796667 | Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System |
| Q37920750 | Kynurenines in Parkinson's disease: therapeutic perspectives. |
| Q29398467 | Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies |
| Q34317484 | Kynurenines in the CNS: recent advances and new questions. |
| Q24647069 | Mammalian nicotinic acetylcholine receptors: from structure to function |
| Q38632327 | Memantine and Kynurenic Acid: Current Neuropharmacological Aspects |
| Q37821333 | Migraine is a neuronal disease |
| Q21710687 | Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders |
| Q24564986 | Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain |
| Q44311666 | Modulatory action of acetylcholine on striatal neurons: microiontophoretic study in awake, unrestrained rats |
| Q42477018 | Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum |
| Q37787553 | Neuronal networks of nicotine addiction |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q45301079 | Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease. |
| Q36555854 | Nicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice(1,2,3). |
| Q35601652 | Nicotine and Parkinson's disease: implications for therapy |
| Q35216455 | Nicotine as a modulator of behavior: beyond the inverted U. |
| Q44620915 | Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex |
| Q26861923 | Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals |
| Q30362437 | Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory |
| Q36882136 | Nicotinic receptors as CNS targets for Parkinson's disease |
| Q42947034 | Nicotinic α7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens |
| Q23918184 | Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum |
| Q41149597 | Pre-synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms |
| Q46285883 | Regulation of glutamate release by heteromeric nicotinic receptors in layer V of the secondary motor region (Fr2) in the dorsomedial shoulder of prefrontal cortex in mouse. |
| Q28583106 | Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals |
| Q34768885 | Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration |
| Q34571365 | SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile |
| Q42580171 | Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats |
| Q36226810 | Section I. The cholinergic system |
| Q50268829 | Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers |
| Q42713160 | Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. |
| Q28648007 | Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia |
| Q26863113 | Striatal cholinergic interneuron regulation and circuit effects |
| Q46386584 | Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine. |
| Q37916643 | Targeting nicotinic receptors for Parkinson's disease therapy |
| Q34276587 | Thalamic glutamate decreases with cigarette smoking |
| Q60732877 | The Role of the Kynurenine Pathway in Neurodegenerative Diseases |
| Q37593550 | The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex |
| Q38171958 | The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors. |
| Q36025622 | The sperm, a neuron with a tail: 'neuronal' receptors in mammalian sperm |
| Q52680310 | The striatal cholinergic system in L-dopa-induced dyskinesias. |
| Q30404614 | Understanding the role α7 nicotinic receptors play in dopamine efflux in nucleus accumbens |
| Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
Search more.